BiotechTube
Home/Imunexus Therapeutics/Dr George Kopsidas
DG

Dr George Kopsidas

Chief Scientific Officer and Founder

Imunexus Therapeutics

Therapeutic Areas

OncologyNeurologyRare Disease

Imunexus Therapeutics Pipeline

DrugIndicationPhase
IMX101Small Cell Lung CancerPreclinical
IMX113Rare Pediatric DiseasePreclinical
IMX39Multiple SclerosisPreclinical

Leadership Team at Imunexus Therapeutics

PL
Philippa Lewis
Executive Director and Chairperson
DB
Don Brumley
Non‑Executive Director
CE
Chris Elliot
Chief Financial Officer and Company Secretary
View full Imunexus Therapeutics profile